As for the clinical utility of measuring the biomarker NT-pro-BNP for prediction of hsPDA, the increase in its plasma concentration is significantly correlated with the increase in the left atrium arising from PDA [40]. This evidence concerns the gene NPPB and Patent ductus arteriosus.